Diagnosis and management of depression and psychosis in children and adolescents with epilepsy

Journal of Child Neurology

Volumn 19, Issue SUPPL. 1, 2004, Pages

  Kanner, Andres M ^a   Dunn, David W ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMOXAPINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOZAPINE; ETHOSUXIMIDE; ETIRACETAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MAPROTILINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; PHENACEMIDE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SERTRALINE; TIAGABINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ANHEDONIA; ANOREXIA; ATAXIA; CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DIARRHEA; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG POTENTIATION; EEG ABNORMALITY; EPILEPSY; EXTRAPYRAMIDAL SYNDROME; FAMILY; HUMAN; INCIDENCE; INSOMNIA; IRRITABILITY; LEUKOPENIA; LOVE; MENTAL DEFICIENCY; MENTAL DISEASE; NEUROLOGIC DISEASE; ORTHOSTATIC HYPOTENSION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK ASSESSMENT; SEIZURE; SYMPTOMATOLOGY; TEMPORAL LOBECTOMY; TREMOR; VERTIGO; VOMITING; XEROSTOMIA;

EID: 8344237540     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380401900108     Document Type: Review

References (83)

1. Hauser WA, Kurland LTI. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975;16:1-66.
2. Cowan LD, Bodenstenier JB, Leviton A, Doherty L: Prevalence of the epilepsies in children and adolescents. Epilepsia 1989;30:94-106.
3. Tsuboi T: Prevalence and incidence of epilepsy in Tokyo. Epilepsia 1988;29:103-110.
4. Rutter M, Graham P, Yule W: The prevalence of psychiatric disorder in neuro-epileptic children, in A Neuropsychiatric Study in Childhood. Clinics in Developmental Medicine, vol 35/36. Philadelphia, JB Lippincott Co, 1970,175-185.
5. Davies S, Heyman I, Goodman R: A population survey of mental health problems in children with epilepsy. Dev Med Child Neurol 2003;45:292-295.
6. Hoare P: The development of psychiatric disorder among school-children with epilepsy. Dev Med Child Neurol 1984;26:3-13.
7. Austin JK, Risinger MW, Beckett LA: Correlates of behavior problems in children with epilepsy. Epilepsia 1992;33:1115-1122.
8. Hoare P, Mann H: Self-esteem and behavioural adjustment in children with epilepsy and children with diabetes. J Psychosom Res 1994;38:859-869.
9. Hoare P, Kerley S: Psychosocial adjustment of children with chronic epilepsy and their families. Dev Med Child Neurol 1991; 33:201-215.
10. Hermann BP, Whitman S, Dell J: Correlates of behavior problems and social competence in children with epilepsy, aged 6-11, in Hermann BP, Seidenberg M (eds): Childhood Epilepsies: Neuropsychological, Psychosocial and Intervention Aspects. New York, John Wiley & Sons Ltd, 1989, 143-157.
11. Caplan R, Gillberg C: Child psychiatric disorders, in Engel J Jr, Pedley TA (eds): Epilepsy: A Comprehensive Textbook. Philadelphia, Lippincott-Raven Publishers, 1997, 2125-2139.
12. Stores G: School-children with epilepsy at risk for learning and behaviour problems. Dev Med Child Neurol 1978;20:502-508.
13. Dunn DW, Austin JK, Huster GA: Symptoms of depression in adolescents with epilepsy. J Am Acad Child Adolesc Psychiatry 1999;38:1132-1138.
14. MacLeod JS, Austin JK: Stigma in the lives of adolescents with epilepsy: A review of the literature. Epilepsy Behav 2003;4:112-117.
15. Weisbrot D, Ettinger AB: Psychiatric aspects of pediatric epilepsy, in Ettinger AB, Kanner AM (eds): Psychiatric Issues in Epilepsy: A Practical Guide to Diagnosis and Treatment. Baltimore, MD, Lippincott Williams & Wilkins, 2001, 127-136.
16. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G: Major depression is a risk factor for seizures in older adults. Ann Neurol 2000;47:246-249.
17. Forsgren L, Nystrom L: An incident case-referent study of epileptic seizures in adults. Epilepsy Res 1990;6:66-81.
18. Ott D, Siddarth P, Gurbani S, et al: Behavioral disorders in pediartic epilepsy: Unmet psychiatric need. Epilepsia 2003;44:591-597.
19. Mendez MF, Doss RC, Taylor JL, Salguero P: Depression in epilepsy. Relationship to seizures and anticonvulsant therapy. J Nerv Ment Dis 1993;181:444-447.
20. Kanner AM, Kozak AM, Frey M: The use of sertraline in patients with epilepsy: Is it safe? Epilepsy Behav 2000;1:100-105.
21. Ettinger AB, Weisbrot DM, Nolan EE, et al: Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998;39:595-599.
22. Kashani JH, Carlson GA, Beck NC, et al: Depression, depressive symptoms, and depressed mood among a community sample of adolescents. Am J Psychiatry 1987;144:931-934.
23. Carlson GA, Cantwell DP: Unmasking masked depression in children and adolescents. Am J Psychiatry 1980;137:445-449.
24. Plioplys S: Depression in children and adolescents with epilepsy. Epilepsy Behav 2003;4(Suppl 3):S39-S45.
25. Angold A, Costello EJ, Messer SC: Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int J Methods Psychiatr Res 1995;5:237-249.
26. Kovacs M: The Children's Depression Inventory (CDI). Psychopharmacol Bull 1985;21:995-998.
27. Gillis JS: Child Anxiety Scale, measurement instrument. Champaign, IL, Institute for Personality and Ability Testing, Inc, 1980.
28. Weissman MM, Wolk S, Goldstein RB, et al: Depressed adolescents grown up. JAMA 1999;281:1707-1713.
29. Borthwick-Duffy SA: Epidemiology and prevalence of psychopathology in people with mental retardation. J Consult Clin Psychol 1994;62:17-27.
30. Lowitzer AC, Utley CA, Baumeister AA: AAMD's 1983 Classification in Mental Retardation as utilized by state mental retardation/developmental disabilities agencies. Ment Retard 1987;25:287-291.
31. Kanner AM: Psychiatric comorbidity in patients with developmental disorders and epilepsy: A practical approach to its diagnosis and treatment. Epilepsy Behav 2002;3(Suppl 6S1):S7-S13.
32. Steffenburg S, Gillberg C, Steffenburg U: Psychiatric disorders in children and adolescents with mental retardation and active epilepsy. Arch Neurol 1996;53:904-912.
33. Diagnostic and Statistical Manual of Mental Disorders-IV-TR Washington, DC, American Psychiatric Association, 2000.
34. Aman MG, Singh NN, Stewart AW, Meld CJ: The Aberrant Behavior Checklist: A behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985;89:485-491.
35. Kazdin AE, Matson JL, Senatore V: Assessment of depression in mentally retarded adults. Am J Psychiatry 1983;140:1040-1043.
36. Feinstein C, Kaminer Y, Barrett RP, Tylenda B: The assessment of mood and affect in developmentally disabled children and adolescents: The Emotional Disorders Rating Scale. Res Dev Disabil 1988;9:109-121.
37. Reiss S: Reiss Screen for Maladaptive Behavior Test Manual measurement instrument. Worthington, OH, International Diagnostic Systems Publishing, 1988.
38. Kanner AM, Palac S: Depression in epilepsy: A common but often unrecognized comorbid malady. Epilepsy Behav 2000;1:37-51.
39. Smith DB, Collins JB: Behavioral effects of carbamazepine, phenobarbital, phenytoin, and primidone, abstract. Epilepsia 1987;28:598.
40. Ring HA, Reynolds EH: Vigabatrin and behaviour disturbance, letter. Lancet 1990;335:970.
41. Kanner AM, Wuu J, Faught E, et al: A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav 2003;4:548-552.
42. Ozawa K, Kobayashi K, Noda S, Iyo M: Zonisamide-induced depression and mania in patients with epilepsy. J Clin Psychopharmacol 2004;24:110-111.
43. Mula M, Trimble MR, Yuen A, et al: Psychiatric adverse events during levetiracetam therapy. Neurology 2003;61:704-706.
44. Ketter TA, Malow BA, Flamini R, et al: Anticonvulsant withdrawal emergent psychopathology. Neurology 1994;44:55-61.
45. Levy RH, Mattson RH, Meldrum BS, Perucca E (eds): Antiepileptic Drugs, 5th ed. Philadelphia, Lippincott Williams & Wilkins, 2002.
46. Kanner AM: Psychosis of epilepsy: A neurologist's perspective. Epilepsy Behav 2000;1:219-227.
47. Kanner AM, Balabanov A: Depression and epilepsy. How closely related are they? Neurology 2002;58(Suppl 5):S27-S39.
48. Preskorn SH, Fast GA: Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry 1992;53:160-162.
49. Curran S, de Pauw K: Selecting an antidepressant for use in a patient with epilepsy. Safety considerations. Drug Saf 1998;18: 125-133.
50. Garcia PA, Alldredge BK: Drug-induced seizures. Neurol Clin 1994;12:85-99.
51. Swinkels JA, de Jonghe F: Safety of antidepressants. Int Clin Psychopharmacol 1995;9(Suppl 4):19-25.
52. McConnell H, Duncan D: Treatment of psychiatric comorbidity in epilepsy, in McConnell HW, Snyder PJ (eds): Psychiatric Comorbirlity in Epilepsy: Basic Mechanisms, Diagnosis and Treatment. Washington, DC, American Psychiatric Press, Inc, 1998, 245-359.
53. Davidson J: Seizures and bupropion: A review. J Clin Psychiatry 1989;50:256-261.
54. Spiller HA, Ramoska EA, Krenzelok EP, et al: Bupropion overdose: A 3-year multi-center retrospective analysis. Am J Emerg Med 1994;12:43-45.
55. Skowron DM, Stimmel GL: Antidepressants and the risk of seizures. Pharmacotherapy 1992;12:18-22.
56. Hazell P, O'Connell D, Heathcote D, Henry D: Tricyclic drugs for depression in children and adolescents (Cochrane Review). The Cochrane Library, Issue 3. Oxford, UK, Update Software, 2003.
57. Keller MB, Ryan ND, Strober M, et al: Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2001;40: 762-772.
58. Hughes CW, Emslie GJ, Crismon ML, et al: The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry 1999; 38:1442-1454.
59. Emslie GJ, Rush AJ, Weinberg WA, et al: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54:1031-1037.
60. Wagner KD, Ambrosini P, Rynn M, et al: Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: Two randomized controlled trials. JAMA 2003;290: 1033-1041.
61. Rayport M, Ferguson SM: Psychosis of epilepsy: An integrated approach, in Ettinger AB, Kanner AM (eds): Psychiatric Issues in Epilepsy: A Practical Guide to Diagnosis and Treatment. Philadelphia, Lippincott Williams & Wilkins, 2001, 73-94.
62. Matsuura M, Trimble MR: Psychoses in epilepsy: A review of Japanese studies. Epilepsy Behav 2000;1:315-326.
63. Caplan R, Arbelle S, Guthrie D, et al: Formal thought disorder and psychopathology in pediatric primary generalized and complex partial epilepsy. J Am Acad Child Adolesc Psychiatry 1997;36: 1286-1294.
64. Sachdev P: Schizophrenia-like psychosis and epilepsy: The status of the association. Am J Psychiatry 1998;155:325-336.
65. Williamson PD, Spencer SS: Clinical and EEG features of complex partial seizures of extratemporal origin. Epilepsia 1986;27(Suppl 2):S46-S63.
66. Logsdail SJ, Toone BK: Post-ictal psychoses. A clinical and phenomenological description. Br J Psychiatry 1988;152:246-252.
67. Nissenkorn A, Moldavsky M, Lorberboym M: Postictal psychosis in a child. J Child Neurol 1999;14:818-819.
68. Pakalnis A, Drake ME, John K, Kellum JB: Forced normalization. Acute psychosis after seizure control in seven patients. Arch Neurol 1987;44:289-292.
69. Adachi N, Matsuura M, Okubo Y, et al: Predictive variables of interictal psychosis in epilepsy. Neurology 2000;55:1310-1314.
70. Wolf P: Acute behavioral symptomatology at disappearance of epileptiform EEG abnormality. Paradoxical or "forced" normalization. Adv Neurol 1991;55:127-142.
71. Iivanainen M, Savolainen H: Side effects of phenobarbital and phenytoin during long-term treatment of epilepsy. Acta Neurol Scand Suppl 1983;97:49-67.
72. Rivinus TM: Psychiatric effects of the anticonvulsant regimens. J Clin Psychopharmacol 1982;2:165-192.
73. Sander JW, Hart YM, Trimble MR, Shorvon SD: Vigabatrin and psychosis. J Neurol Neurosurg Psychiatry 1991;54:435-439.
74. Ben-Menachem E, French J: Vigabatrin, in Engel J Jr, Pedley TA (eds): Epilepsy: A Comprehensive Textbook. Philadelphia, Lippincott-Raven Publishers, 1997,1609-1618.
75. Miyamoto T, Kohsaka M, Koyama T: Psychotic episodes during zonisamide treatment. Seizure 2000;9:65-70.
76. Manchanda R, Miller H, McLachlan RS: Post-ictal psychosis after right temporal lobectomy. J Neurol Neurosurg Psychiatry 1993;56: 277-279.
77. Leinonen E, Tuunainen A, Lepola U: Postoperative psychoses in epileptic patients after temporal lobectomy. Acta Neurol Scand 1994;90:394-399.
78. Mace CJ, Trimble MR: Psychosis following temporal lobe surgery: A report of six cases. J Neurol Neurosurg Psychiatry 1991;54: 639-644.
79. Taylor DC: Factors influencing the occurrence of schizophrenia-like psychosis in patients with temporal lobe epilepsy. Psychol Med 1975;5:249-254.
80. Whitworth AB, Fleischhacker WW. Adverse effects of antipsychotic drugs. Int Clin Psychopharmacol 1995;9(Suppl 5):21-27.
81. Logothetis J: Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy. Neurology 1967;17:869-877.
82. Pacia SV, Devinsky O: Clozapine-related seizures: Experience with 5,629 patients. Neurology 1994;44:2247-2249.
83. Tiihonen J, Nousiainen U, Hakola P, et al: EEG abnormalities associated with clozapine treatment, letter. Am J Psychiatry 1991;148:1406.